Project Grant R01DA064519
- The National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 - Drug Use and Addiction Research Programs, awarded a $1,548,605 Project Grant to the University of Massachusetts Medical School (UMMS) to test the effectiveness of the Jail ECHO Operations, Planning, and Strategy (J-ECHO OPS) implementation strategy to increase access to Medication for Opioid Use Disorder (MOUD) in rural jails. The study, titled "Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail...
- The National Institute on Drug Abuse (NIDA) has awarded a $731,275 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Massachusetts Medical School (UMMS) to support the "Supporting Treatment Access and Recovery in Re-entry (STAR-R)" study. The 5-year study will evaluate the effectiveness of the "Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice Version (MISSION-CJ)"...
- This $575,433 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a research study titled "Hybrid Trial of Peer-Supported Affect Regulation and Contingency Management to Improve HIV Prevention Outcomes in the Southern United States". The grant aims to develop, pilot, and evaluate a scalable intervention called "SHE CARES" that combines contingency management and positive affect strategies to...
- This federal Project Grant award of $661,850 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports a hybrid Type I trial to assess the effectiveness and implementation of a peer-led court navigator program that facilitates linkage to substance use disorder treatment. The award will fund a randomized controlled trial to compare the effectiveness of the court...
- This federal Project Grant award of $742,500 from the National Institute on Drug Abuse (NIDA), which is part of the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on a peer recovery coaching intervention to promote tobacco abstinence among individuals with opioid use disorder. The award will fund a 3-year pilot study to adapt a behavioral tobacco use disorder (TUD) intervention called PEERTTS for people with opioid use disorder and TUD, and to train peer recovery...
- This $1,445,488 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to continue the work of the Kentucky Women's Justice Community Overdose Innovation Network - Phase II (WJCOIN-II). The project's overall goal is to reduce overdose risk among women during their re-entry from jail to rural communities in Kentucky. Specific objectives include: Comparing the effectiveness of pre-release Recovery Coaching (RC)...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a clinical research hub to study the implementation and impact of a Medicaid Inmate Exclusion Policy (MIEP) waiver in 4 Massachusetts county jails. The $1,600,955 award, effective from Sep 1, 2025 to May 31, 2030, will be administered by the University of Massachusetts. The research aims to understand how the MIEP waiver, which...
- This Project Grant award of $2,332,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to better address HIV, HIV risk, and substance use disorders. The key products and services to be delivered include: Building the foundation for a "prison learning health system" to improve the quality, efficiency, and reach of HIV treatment, HIV prevention, and...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to optimize opioid use disorder (OUD) treatment in prisons. The key products and services to be delivered include: Validating a 2-item OUD screening tool and an 11-item diagnostic DSM-5 OUD symptom checklist adapted for use in prisons. This will involve validating these tools against...
This $576,900 project grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will implement and evaluate a peer recovery coach (PRC) program at three high-throughput jails in the Atlanta, Georgia area. The program aims to improve access to substance use disorder (SUD) treatment and medications for opioid use disorder (MOUD) for individuals in these jails, particularly Black individuals and those experiencing homelessness who face disproportionate barriers to care. The project will adapt an established SUD virtual PRC model (LINCS UP) for the jail setting, guided by the EPIS framework and developed in collaboration with a community advisory board. The program outcomes will be measured across the RE-AIM framework to assess reach, effectiveness, adoption, implementation, and maintenance. The grant period runs from September 15, 2025 through May 31, 2030, with the awardee being Emory University, a private research university in Atlanta.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $576.9k | 9/8/25 |